Staphylococcus aureus (S. aureus, or ‘golden staph’) bloodstream infections (SABSI) associated with hospital care can be serious, particularly when bacteria are resistant to common antimicrobials.
In 2019–20, all states and territories had public hospital SABSI rates below the national benchmark of 2.0 cases per 10,000 patient days.
Over the past 5 years, the SABSI rate has fluctuated at around 0.7, for instance, 0.74 in 2015–16 and 0.71 in 2019–20.